UNICYCIVE THERAPEUTICS INC shareholders Q3 2023

UNICYCIVE THERAPEUTICS INC's ticker is and the CUSIP is 90466Y103. A total of 17 filers reported holding UNICYCIVE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

UNICYCIVE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Vivo Capital, LLC 3,470,152$2,984,3310.33%
Nantahala Capital Management 3,470,541$2,984,6660.26%
BVF INC/IL 3,413,563$2,935,6640.08%
RA Capital Management 3,470,688$2,984,7920.06%
TANDEM CAPITAL MANAGEMENT CORP /ADV 31,000$26,6600.01%
Virtu Financial LLC 10,994$90.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 52,399$45,0630.00%
STATE STREET CORP 35,036$30,1310.00%
GOLDMAN SACHS GROUP INC 93,233$80,1800.00%
TWO SIGMA SECURITIES, LLC 11,165$9,6020.00%
CAPTRUST FINANCIAL ADVISORS 18,800$16,1680.00%
Beacon Pointe Advisors, LLC 11,861$10,2000.00%
Tower Research Capital LLC (TRC) 3,068$2,6380.00%
VANGUARD GROUP INC 115,057$98,9490.00%
UBS Group AG 718$6170.00%
WELLS FARGO & COMPANY/MN 39$340.00%

This page lists UNICYCIVE THERAPEUTICS INC's shareholders in Q3 2023. To view UNICYCIVE THERAPEUTICS INC's shareholder history, click here.